Navigation Links
Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
Date:5/13/2008

See oncologists as often as whites, researchers not sure why different choices of treatment follow

TUESDAY, May 13 (HealthDay News) -- Even though black and white rectal cancer patients have similar referral rates to oncologists, blacks are less likely to receive chemotherapy or radiation therapy, new research shows.

In their study, researchers from the University of Michigan Comprehensive Cancer Center looked at 2,582 white patients and 134 black patients, aged 66 and older.

The study found that 75 percent of whites and 73 percent of blacks saw an oncologist after being diagnosed with rectal cancer, but only 54 percent of blacks received chemotherapy, compared with 70 percent of whites. In addition, rates of referral to a radiation oncologist were similar, but only 74 percent of blacks received radiation therapy, compared with 83 percent of whites.

The findings were published in the May 13 online issue of the Journal of the National Cancer Institute.

"Although there wasn't a discrepancy between African-Americans and whites in the rates of consultation with an oncologist, we found a large discrepancy in the receipt of chemotherapy. This is very important. We knew that African-Americans were not receiving chemotherapy for rectal cancer at the same rates as white Americans, and it was contributing to their increased mortality. Now we have a better idea of where the problem lies: somewhere between the visit with the oncologist and the actual initiation of chemotherapy," study author Dr. Arden Morris, an assistant professor of surgery at the U-M Medical School and chief of general surgery at the VA Ann Arbor Healthcare System, said in a prepared statement.

Compared to whites, blacks have as much as a 20 percent worse long-term survival rate after rectal cancer surgery. It's known that the use of chemotherapy and radiation improves survival in all rectal cancer patients by as much as 20 percent. It's believed that the lack of chemotherapy and radiation treatment in blacks is largely responsible for their lower long-term survival rates.

"We now know that the initial visit with an oncologist is not the barrier to treatment. Our next step is to better understand what are the human factors that contribute to this discrepancy. We're interested in hearing what individual people have to say," Morris said.

She and her colleagues suspect social differences and priorities among different groups -- such as patient preferences or access to resources such as transportation or family care -- may contribute to these discrepancies.

"Choice is important. If there's a choice, this maybe isn't a disparity but a preference. But if it's not a choice, then we need to understand the barriers and find solutions," Morris said.

In her next study, she plans to interview patients who've been treated for colorectal cancer to learn how they reached the decision to have chemotherapy or whether they feel they even made that decision themselves.

More information

The U.S. National Cancer Institute has more about colorectal cancer.



-- Robert Preidt



SOURCE: University of Michigan news release, May 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Media Alert: 100 Black Men of Atlanta Host 3rd Annual Community Health Fair
2. Black women have urinary incontinence less than half as often as white women
3. Gene Variant Protects Black Heart Failure Patients
4. Muscle Mass May Not Explain High Creatinine in Black Kidney Patients
5. Blackstone Sells Gerresheimer Stake
6. Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use
7. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
8. Joint Center to Focus on Issues of Health Equity During Congressional Black Caucus Spring Health Braintrust
9. High-Risk Blacks Less Likely to Get Colonoscopies
10. Black Infants Are More Likely to Be Born Preterm and to Die at Birth
11. Glaucoma May Boost Cardiovascular Death Risk in Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: